MAIA Biotechnology, Inc. (MAIA)
1.325
+0.02
(+1.15%)
USD |
NYAM |
Sep 21, 16:00
1.33
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Price to Book Value : 3.898 for Sept. 21, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 3.854 |
| September 17, 2026 | 4.118 |
| September 16, 2026 | 4.118 |
| September 15, 2026 | 3.942 |
| September 14, 2026 | 4.089 |
| September 11, 2026 | 3.824 |
| September 10, 2026 | 3.854 |
| September 09, 2026 | 3.912 |
| September 08, 2026 | 3.854 |
| September 04, 2026 | 3.883 |
| September 03, 2026 | 3.912 |
| September 02, 2026 | 4.03 |
| September 01, 2026 | 3.824 |
| August 31, 2026 | 3.854 |
| August 28, 2026 | 3.912 |
| August 27, 2026 | 4.059 |
| August 26, 2026 | 4.089 |
| August 25, 2026 | 4.148 |
| August 24, 2026 | 3.971 |
| August 21, 2026 | 4.089 |
| August 20, 2026 | 4.059 |
| August 19, 2026 | 4.089 |
| August 18, 2026 | 4.03 |
| August 17, 2026 | 4.089 |
| August 14, 2026 | 4.118 |
| Date | Value |
|---|---|
| August 13, 2026 | 3.942 |
| August 12, 2026 | 4.059 |
| August 11, 2026 | 4.059 |
| August 10, 2026 | 4.148 |
| August 07, 2026 | 4.177 |
| August 06, 2026 | 4.177 |
| August 05, 2026 | 4.118 |
| August 04, 2026 | 4.001 |
| August 03, 2026 | 3.883 |
| July 31, 2026 | 3.677 |
| July 30, 2026 | 3.677 |
| July 29, 2026 | 3.530 |
| July 28, 2026 | 3.648 |
| July 27, 2026 | 3.765 |
| July 24, 2026 | 3.648 |
| July 23, 2026 | 3.765 |
| July 22, 2026 | 3.824 |
| July 21, 2026 | 3.912 |
| July 20, 2026 | 3.765 |
| July 17, 2026 | 3.824 |
| July 16, 2026 | 3.912 |
| July 15, 2026 | 4.324 |
| July 14, 2026 | 4.236 |
| July 13, 2026 | 4.177 |
| July 10, 2026 | 4.236 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.603 |
| ACADIA Pharmaceuticals, Inc. | 3.477 |
| Alnylam Pharmaceuticals, Inc. | 24.12 |
| Anika Therapeutics, Inc. | 2.020 |
| Savara, Inc. | 7.799 |
Price to Book Value Related Metrics
| PEG Ratio | -0.2865 |
| Price | 1.325 |
| Earnings Yield | -47.83% |
| Market Cap | 80.58M |
| PEGY Ratio | -0.2865 |